Richard Aguilar - 18 Jan 2022 Form 4 Insider Report for Cano Health, Inc.

Role
Chief Clinical Officer
Signature
/s/ David J. Armstrong, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
18 Jan 2022
Net transactions value
$0
Form type
4
Filing time
20 Jan 2022, 15:05:14 UTC
Previous filing
14 Feb 2022
Next filing
17 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CANO Class A Common Stock Award +200,000 +35% 771,229 18 Jan 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest as to 25% of the RSUs on June 3, 2022 and each year thereafter.
F2 These shares include 41,334 shares of Class A Common Stock acquired under the Cano Health, Inc. 2021 Employee Stock Purchase Plan on January 10, 2022.